Cannabidiol (active substance cbd) therapeutic uses

Can we legally purchase and take in marijuana in France today? Yes and no. Yes, because the state has unwinded its policies on CBD, including through the Minister of Health. And no, at the same time, because just products including cannabidiol (CBD), an active substance that does not have the psychoactive impacts attributed to THC, are considered legal. Let us take stock of what is legal and what is not with regard to marijuana and provision CBD.

CBD is legal in France, but THC is not

Marijuana must not be confused with cannabidiol. Specifically considering that the 2nd is legal in particular forms in France … While the other is not! Due to the fact that cannabidiol (understood by the acronym CBD) is simply among the many active compounds from the hemp plant, which does not have the psychoactive impacts of its cousin THC – the one that makes you “stone”.

In short, what is typically called “marijuana”, which contains high concentrations of THC (tetrahydrocannabinol) is still considered a narcotic product. And therefore prohibited in France as in lots of countries on the planet. On the other hand, marijuana which provides pride of place to the cannabinoid called cannabidiol, it is legal as long as its THC levels do not surpass 0.2%.

Nevertheless, the legislation stays unclear in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is authorized for sale in the form of E-liquid, to be used in an e cigarette. But it is likewise found in other forms (including oil or paste), without its purchase and usage being reprehensible … To try to make it basic, let’s state that CBD is not forbidden by French law, unlike THC


Although lake shore CBD and THC are equivalent, they are very various. These are the very best understood of the 500 cannabinoids found in hemp. And each has its specific impacts. THC is especially understood for its psychoactive properties: it causes a modification in the state of awareness by acting straight on the brain. By consuming marijuana abundant in THC, we “hover”: well-being, ecstasy, relaxation … But likewise red eyes, dilated students and, sometimes, stress and anxiety and even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not cause stress and anxiety or stress and anxiety attacks. On the contrary: cannabidiol is in the process of making its way by virtue of its advantageous restorative impacts. CBD helps alleviate discomfort and inflammation, minimize stress and anxiety, relieve the suffering of victims of stress and anxiety attacks and anxiety, and even treat particular diseases (such as epilepsy or Alzheimer’s). In addition, it has a very low toxicity and presents (nearly) no addicting danger, even if the lack of clinical studies lowers these attributes to simple hypotheses.

Legalization of CBD in France: should we go even more?

Certainly, the legal development concerning CBD is positive, but everything stays to be done. The health ministry wishes to be cautious, and the government’s position on the matter looks like a balancing act. At the same time, the National Medicines Agency has plainly spoken up. We therefore look after the goat and the cabbage so as not to get too involved, while the vaporized cannabidiol has been offered in France for a few years already, taking advantage of the legal vagueness that continues.

Beyond the 0.2% THC limit authorized in marketed products, it must be borne in mind that just the liquid kind of CBD (planned for electronic cigarettes) is actually legal. The purchase and usage of resin or cigarette smoking herb is therefore not controlled, particularly considering that the THC level is frequently higher (around 15%). In addition, just making use of seeds and fibers is authorized in France. But what about CBD oil, which enables you to enjoy the benefits of the substance without exposing your lungs to potentially hazardous smoke? What about CBD paste? On these subjects, there is radio silence.

In addition, CBD is considered a “dietary supplement”, which prohibits providing it as a medication. And make it an enlightened advertisement for users and patients. Too bad, because, in the meantime, lots of potential beneficiaries are not taking advantage of it. It is therefore essential to go even more and clarify things: more than a question of customer well-being, it is a matter of public health.

Scroll to top